Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 120

1.
2.

Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non-small cell lung cancer.

Tarhini AA, Rafique I, Floros T, Tran P, Gooding WE, Villaruz LC, Burns TF, Friedland DM, Petro DP, Farooqui M, Gomez-Garcia J, Gaither-Davis A, Dacic S, Argiris A, Socinski MA, Stabile LP, Siegfried JM.

Cancer. 2017 Aug 1;123(15):2936-2944. doi: 10.1002/cncr.30717. Epub 2017 May 4.

PMID:
28472537
3.

Results of a Single Institution Experience with Dose-Escalated Chemoradiation for Locally Advanced Unresectable Non-Small Cell Lung Cancer.

Bernard ME, Glaser SM, Gill BS, Beriwal S, Heron DE, Luketich JD, Friedland DM, Socinski MA, Greenberger JS.

Front Oncol. 2017 Jan 23;7:1. doi: 10.3389/fonc.2017.00001. eCollection 2017.

4.

Improving Conduct and Feasibility of Clinical Trials to Evaluate Antibacterial Drugs to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia: Recommendations of the Clinical Trials Transformation Initiative Antibacterial Drug Development Project Team.

Knirsch C, Alemayehu D, Botgros R, Comic-Savic S, Friedland D, Holland TL, Merchant K, Noel GJ, Pelfrene E, Reith C, Santiago J, Tiernan R, Tenearts P, Goldsack JC, Fowler VG Jr.

Clin Infect Dis. 2016 Aug 15;63 Suppl 2:S29-36. doi: 10.1093/cid/ciw258.

PMID:
27481950
5.

Association of TMTC2 With Human Nonsyndromic Sensorineural Hearing Loss.

Runge CL, Indap A, Zhou Y, Kent JW Jr, King E, Erbe CB, Cole R, Littrell J, Merath K, James R, Rüschendorf F, Kerschner JE, Marth G, Hübner N, Göring HH, Friedland DR, Kwok WM, Olivier M.

JAMA Otolaryngol Head Neck Surg. 2016 Sep 1;142(9):866-72. doi: 10.1001/jamaoto.2016.1444.

6.

Development of a Statistical Model for the Prediction of Common Vestibular Diagnoses.

Friedland DR, Tarima S, Erbe C, Miles A.

JAMA Otolaryngol Head Neck Surg. 2016 Apr;142(4):351-6. doi: 10.1001/jamaoto.2015.3663.

7.

Post-traumatic amnesia and confusional state: hazards of retrospective assessment.

Friedland D, Swash M.

J Neurol Neurosurg Psychiatry. 2016 Oct;87(10):1068-74. doi: 10.1136/jnnp-2015-312193. Epub 2016 Feb 17. Review.

PMID:
26888959
8.

Differences in Perception of Musical Stimuli among Acoustic, Electric, and Combined Modality Listeners.

Prentiss SM, Friedland DR, Nash JJ, Runge CL.

J Am Acad Audiol. 2015 May;26(5):494-501. doi: 10.3766/jaaa.14098.

PMID:
26055838
9.

Smartphone technology: Gentle reminders of everyday tasks for those with prospective memory difficulties post-brain injury.

Ferguson S, Friedland D, Woodberry E.

Brain Inj. 2015;29(5):583-91. doi: 10.3109/02699052.2014.1002109. Epub 2015 Jan 27.

PMID:
25625598
10.

Evidence-based Medicine: A Framework for Emotional Regulation, Intuition, and Conscious Engagement.

Friedland D.

Glob Adv Health Med. 2014 Mar;3(2):3-4. doi: 10.7453/gahmj.2014.026. No abstract available.

11.

Patient Outcomes in Magnet-Based Implantable Auditory Assist Devices.

O'Niel MB, Runge CL, Friedland DR, Kerschner JE.

JAMA Otolaryngol Head Neck Surg. 2014 Jun;140(6):513-20. doi: 10.1001/jamaoto.2014.484.

PMID:
24763485
12.

A phase I, open-label study of trebananib combined with sorafenib or sunitinib in patients with advanced renal cell carcinoma.

Hong DS, Gordon MS, Samlowski WE, Kurzrock R, Tannir N, Friedland D, Mendelson DS, Vogelzang NJ, Rasmussen E, Wu BM, Bass MB, Zhong ZD, Friberg G, Appleman LJ.

Clin Genitourin Cancer. 2014 Jun;12(3):167-177.e2. doi: 10.1016/j.clgc.2013.11.007. Epub 2013 Nov 13.

13.

The perception of telephone-processed speech by combined electric and acoustic stimulation.

Hu Y, Tahmina Q, Runge C, Friedland DR.

Trends Amplif. 2013 Sep-Dec;17(3):189-96. doi: 10.1177/1084713813512901. Epub 2013 Nov 20.

14.

A novel otoferlin splice-site mutation in siblings with auditory neuropathy spectrum disorder.

Runge CL, Erbe CB, McNally MT, Van Dusen C, Friedland DR, Kwitek AE, Kerschner JE.

Audiol Neurootol. 2013;18(6):374-82. doi: 10.1159/000354978. Epub 2013 Oct 15.

15.

How do experts reporting for the legal process validate symptoms? The results of a survey.

Allcott D, Anderson S, Friedland D, Leng N, Gross M, Skelton-Robinson M, Weller M.

Med Sci Law. 2014 Apr;54(2):68-73. doi: 10.1177/0025802413491247. Epub 2013 Aug 21.

PMID:
23966354
16.

Falls and traumatic brain injury in adults under the age of sixty.

Friedland D, Brunton I, Potts J.

J Community Health. 2014 Feb;39(1):148-50. doi: 10.1007/s10900-013-9752-3.

PMID:
23963854
17.

A multicenter phase II study of cetuximab in combination with chest radiotherapy and consolidation chemotherapy in patients with stage III non-small cell lung cancer.

Ramalingam SS, Kotsakis A, Tarhini AA, Heron DE, Smith R, Friedland D, Petro DP, Raez LE, Brahmer JR, Greenberger JS, Dacic S, Hershberger P, Landreneau RJ, Luketich JD, Belani CP, Argiris A.

Lung Cancer. 2013 Sep;81(3):416-21. doi: 10.1016/j.lungcan.2013.06.002. Epub 2013 Jul 10.

PMID:
23849982
18.

Statistical model for prediction of hearing loss in patients receiving cisplatin chemotherapy.

Johnson A, Tarima S, Wong S, Friedland DR, Runge CL.

JAMA Otolaryngol Head Neck Surg. 2013 Mar;139(3):256-64. doi: 10.1001/jamaoto.2013.1713. Erratum in: JAMA Otolaryngol Head Neck Surg. 2013 Oct;139(10):1.

PMID:
23429908
19.

Mechanism-based model characterizing bidirectional interaction between PEGylated liposomal CKD-602 (S-CKD602) and monocytes in cancer patients.

Wu H, Ramanathan RK, Zamboni BA, Strychor S, Ramalingam S, Edwards RP, Friedland DM, Stoller RG, Belani CP, Maruca LJ, Bang YJ, Zamboni WC.

Int J Nanomedicine. 2012;7:5555-64. doi: 10.2147/IJN.S35751. Epub 2012 Oct 19.

20.

Single and multiple microphone noise reduction strategies in cochlear implants.

Kokkinakis K, Azimi B, Hu Y, Friedland DR.

Trends Amplif. 2012 Jun;16(2):102-16. doi: 10.1177/1084713812456906. Epub 2012 Aug 23. Review.

Supplemental Content

Loading ...
Support Center